FDA Pulmonary Hypertension Patient Meeting Follows Two Recent Approvals
This article was originally published in The Pink Sheet Daily
Executive Summary
In announcing the May 13 meeting, FDA asks whether pulmonary arterial hypertension medications have made a difference to patients with the condition.